+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Diamyd Medical AB (DMYD B) - Financial and Strategic SWOT Analysis Review

  • ID: 4284763
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug company that concentrates on the development of therapies for autoimmune diabetes. The company is developing diabetes vaccine, Diamyd, an Antigen Based Therapy (ABT). It develops therapies based on its in-licensed substances GAD, GABA and Gliadin for the prevention and treatment of autoimmune diabetes and other inflammation-related conditions. Its GAD is the active ingredient in the diabetes vaccine Diamyd; GABA (gamma-aminobutyric acid) is synthesized from the amino acid glutamate in cells by the enzyme GAD; and Gliadin is a constituent of gluten protein found in wheat and some other cereals. The company invests in the stem cell and medical technology. Diamyd is headquartered in Stockholm, Sweden.

Diamyd Medical AB Key Recent Developments

Oct 11, 2017: Diamyd Medical : Financial Statement 16/17
Apr 05, 2017: Diamyd Medical: Quarterly Report II 16/17
Jan 25, 2017: Diamyd Medical: Quarterly Report I 16/17
Jan 10, 2017: GABA-specialist to the Board of Diamyd Medical

This comprehensive SWOT profile of Diamyd Medical AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Diamyd Medical AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Diamyd Medical AB - Key Information
  • Diamyd Medical AB - Overview
  • Diamyd Medical AB - Key Employees
  • Diamyd Medical AB - Key Employee Biographies
  • Diamyd Medical AB - Key Operational Heads
  • Diamyd Medical AB - Major Products and Services
  • Diamyd Medical AB - History
  • Diamyd Medical AB - Company Statement
  • Diamyd Medical AB - Locations And Subsidiaries
  • Diamyd Medical AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Diamyd Medical AB - Business Description
  • Diamyd Medical AB - Corporate Strategy
  • Diamyd Medical AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Diamyd Medical AB - Strengths
  • Diamyd Medical AB - Weaknesses
  • Diamyd Medical AB - Opportunities
  • Diamyd Medical AB - Threats
  • Diamyd Medical AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • Diamyd Medical AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Diamyd Medical AB, Key Information
  • Diamyd Medical AB, Key Ratios
  • Diamyd Medical AB, Share Data
  • Diamyd Medical AB, Major Products and Services
  • Diamyd Medical AB, History
  • Diamyd Medical AB, Key Employees
  • Diamyd Medical AB, Key Employee Biographies
  • Diamyd Medical AB, Key Operational Heads
  • Diamyd Medical AB, Other Locations
  • Diamyd Medical AB, Subsidiaries
  • Diamyd Medical AB, Key Manufacturing facilities
  • Diamyd Medical AB, Key Competitors
  • Diamyd Medical AB, SWOT Analysis
  • Diamyd Medical AB, Ratios based on current share price
  • Diamyd Medical AB, Annual Ratios
  • Diamyd Medical AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Diamyd Medical AB, Performance Chart
  • Diamyd Medical AB, Ratio Charts
Note: Product cover images may vary from those shown